Abstract

Background: With an increase in comprehension of the molecular biology of viruses, there has been a recent surge in the application of virus sequences and viral gene expression strategies towards the diagnosis and treatment of diseases.

Results: The scope of the patenting landscape has widened as a result and the current review discusses patents pertaining to live / attenuated viral vaccines. The vaccines addressed here have been developed by both conventional means as well as by the state-of-the-art genetic engineering techniques.

Conclusion: This review also addresses the applications of these patents for clinical and biotechnological purposes.

Keywords: Attenuated virus, vaccines, antiviral agents, inactivated viruses, virulence factors, adjuvants.

Graphical Abstract